Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group. Mazzaferro V, et al. Among authors: gerunda ge. Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5. Epub 2008 Dec 4. Lancet Oncol. 2009. PMID: 19058754
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.
Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group. Avolio AW, et al. Among authors: gerunda ge. Am J Transplant. 2011 Dec;11(12):2724-36. doi: 10.1111/j.1600-6143.2011.03732.x. Epub 2011 Sep 15. Am J Transplant. 2011. PMID: 21920017 Free article.
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
Angelico M, Nardi A, Romagnoli R, Marianelli T, Corradini SG, Tandoi F, Gavrila C, Salizzoni M, Pinna AD, Cillo U, Gridelli B, De Carlis LG, Colledan M, Gerunda GE, Costa AN, Strazzabosco M; Liver Match Study Investigators. Angelico M, et al. Among authors: gerunda ge. Dig Liver Dis. 2014 Apr;46(4):340-7. doi: 10.1016/j.dld.2013.11.004. Epub 2014 Jan 9. Dig Liver Dis. 2014. PMID: 24411484 Free article.
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F; Liver Match Investigators. Angelico M, et al. Among authors: gerunda ge. Dig Liver Dis. 2011 Feb;43(2):155-64. doi: 10.1016/j.dld.2010.11.002. Epub 2010 Dec 24. Dig Liver Dis. 2011. PMID: 21185796
Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study.
Ballarin R, Cucchetti A, Spaggiari M, Montalti R, Di Benedetto F, Nadalin S, Troisi RI, Valmasoni M, Longo C, De Ruvo N, Cautero N, Cillo U, Pinna AD, Burra P, Gerunda GE. Ballarin R, et al. Among authors: gerunda ge. Transplantation. 2011 Jun 15;91(11):1265-72. doi: 10.1097/TP.0b013e318219eb8f. Transplantation. 2011. PMID: 21478815
Hepatocellular carcinoma in HIV patients treated by liver transplantation.
Di Benedetto F, De Ruvo N, Berretta M, Masetti M, Montalti R, Di Sandro S, Ballarin R, Codeluppi M, Guaraldi G, Gerunda GE. Di Benedetto F, et al. Among authors: gerunda ge. Eur J Surg Oncol. 2008 Apr;34(4):422-7. doi: 10.1016/j.ejso.2007.05.004. Epub 2007 Jun 25. Eur J Surg Oncol. 2008. PMID: 17590564
Absence of viable HCC in the native liver is an independent protective factor of tumor recurrence after liver transplantation.
Montalti R, Mimmo A, Rompianesi G, Di Gregorio C, Serra V, Cautero N, Ballarin R, Spaggiari M, Tarantino G, D'Amico G, De Santis M, De Pietri L, Troisi RI, Gerunda GE, Di Benedetto F. Montalti R, et al. Among authors: gerunda ge. Transplantation. 2014 Jan 27;97(2):220-6. doi: 10.1097/TP.0b013e3182a8607e. Transplantation. 2014. PMID: 24056629
Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment.
Ravaioli M, Masetti M, Ridolfi L, Capelli M, Grazi GL, Venturoli N, Di Benedetto F, Bianchi FB, Cavrini G, Faenza S, Begliomini B, Pinna AD, Gerunda GE, Ballardini G. Ravaioli M, et al. Among authors: gerunda ge. Transplantation. 2007 Apr 15;83(7):919-24. doi: 10.1097/01.tp.0000259251.92398.2a. Transplantation. 2007. PMID: 17460563
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation.
Salizzoni M, Cavallari A, Risaliti A, Filipponi F, Gerunda GE, Forti D, Fassati LR, Cillo U, Castagneto M, Valente U, Tisone G. Salizzoni M, et al. Among authors: gerunda ge. Transplant Proc. 2001 May;33(3):2258-62. doi: 10.1016/s0041-1345(01)01983-2. Transplant Proc. 2001. PMID: 11377521 Clinical Trial. No abstract available.
162 results